1. Home
  2. LGVN vs FTFT Comparison

LGVN vs FTFT Comparison

Compare LGVN & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • FTFT
  • Stock Information
  • Founded
  • LGVN 2014
  • FTFT N/A
  • Country
  • LGVN United States
  • FTFT United States
  • Employees
  • LGVN N/A
  • FTFT N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • FTFT Business Services
  • Sector
  • LGVN Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • LGVN 31.2M
  • FTFT 8.4M
  • IPO Year
  • LGVN 2021
  • FTFT N/A
  • Fundamental
  • Price
  • LGVN $2.91
  • FTFT $0.47
  • Analyst Decision
  • LGVN Strong Buy
  • FTFT
  • Analyst Count
  • LGVN 1
  • FTFT 0
  • Target Price
  • LGVN $12.00
  • FTFT N/A
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • FTFT 149.0K
  • Earning Date
  • LGVN 08-09-2024
  • FTFT 08-19-2024
  • Dividend Yield
  • LGVN N/A
  • FTFT N/A
  • EPS Growth
  • LGVN N/A
  • FTFT N/A
  • EPS
  • LGVN N/A
  • FTFT N/A
  • Revenue
  • LGVN $978,000.00
  • FTFT $36,594,555.00
  • Revenue This Year
  • LGVN $137.24
  • FTFT N/A
  • Revenue Next Year
  • LGVN $50.77
  • FTFT N/A
  • P/E Ratio
  • LGVN N/A
  • FTFT N/A
  • Revenue Growth
  • LGVN N/A
  • FTFT 53.89
  • 52 Week Low
  • LGVN $0.77
  • FTFT $0.40
  • 52 Week High
  • LGVN $35.60
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 51.81
  • FTFT 39.00
  • Support Level
  • LGVN $2.90
  • FTFT $0.40
  • Resistance Level
  • LGVN $4.88
  • FTFT $0.49
  • Average True Range (ATR)
  • LGVN 0.70
  • FTFT 0.05
  • MACD
  • LGVN -0.04
  • FTFT 0.01
  • Stochastic Oscillator
  • LGVN 27.59
  • FTFT 48.57

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: